Resources
For the latest in precision medicine, sign up for our monthly newsletter to be among the first to receive
exclusive insights, in-depth market analyses, and expert articles directly to your inbox
On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Accelerate Protein Screening by Sequencing Protein Barcodes on Platinum®
On-demand webinar presented by Joel McDade, PhD, Sr. Commercial Business Development Manager, Quantum-Si and Bonnie Lun, PhD, Field Application Scientist
Challenges and Strategies for the Application of Omics and Spatial Technologies
A concise report featuring insights from the prominent thought leaders of Omics 2023 and Spatial 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
NGS
CareDx and Dovetail Genomics to Collaborate on NGS Workflow for Transplant HLA Matching
HLA matching is critical for successful transplants. The two companies hope combining their technologies will improve testing; and therefore, patient outcomes.
Clinical Diagnostics
WHO Publishes Preferred Product Characteristics for Alzheimer’s Blood Tests
The PPC outlines guidance for the development of blood tests for Alzheimer's, including important considerations to increase accessibility and diversity.
Diagnostic Development
Imaging Starts Using Brand New Radiotracer from Nuclidium
The radiotracer is the first part of Nuclidium’s proposed ‘theranostic pipeline’ which aims to diagnose, stage, and then treat prostate cancer.
Biomarker Analysis
Etcembly Partner With University of Surrey to Learn From Long Term Cancer Survivors’ T Cells
The analysis of cancer survivors’ T cell receptors may yield fresh targets for immunotherapies.
Diagnostic Development
GHR Foundation Commits $15m to C2N Diagnostics for Tau Tangle Pathology Test for Diagnosing, Staging Alzheimer’s Disease
GHR’s total investment in C2N has now broken $50 million since 2020.
Single Cell Analysis
New Research From Indivumed Tx Highlights Importance of Snap Freezing Tumour Samples in Target Discovery and Cancer Therapy Development
Tumour samples which were frozen after more than ten minutes were significantly different in molecular biology to samples which were frozen in less than 10 minutes.
Single Cell Analysis
National University of Singapore Unveil Novel Single-Cell RNA Analysis Technique
The novel technique effectively denoises scRNA-seq data by fitting a low-dimensional manifold in the high-dimensional space.
Biomarker Analysis
Study Analyses Predictive Biomarkers for COVID-19 ICU Patient Mortality
The study from the Federal University of Paraíba, Brazil analyses a series of haematological, biochemical, and inflammatory factors all contribute to the mortality of COVID-19 patients in the ICU.
Clinical Diagnostics
AI Analysis of Patient Serum Presents Promising New Lyme Disease Diagnosis Tool
The AI-enabled immunological approach aims to bring accurate diagnoses faster and sooner after potential infection.
Personalised Medicine
Group Identify Prognostic Biomarker for SCLC and Treatment Using Chemotherapy
SCLC patients that express the gene PCDHB4 have a higher likelihood of developing a resistance to chemotherapy.
Biomarker Discovery & Development
Proteomic Analysis of Serum Extracellular Vesicles Reveals Potential Biomarkers for Neuroblastoma
The proteomic analysis of extracellular vesicles is shaping up to be a promising biomarker discovery technique for diseases like neuroblastoma.
NGS Bioinformatics
Novel Proteomics Biomarkers Show Potential for TB Lateral Flow Test
Earlier diagnosis of tuberculosis using an easy to use proteomic panel could save millions of lives from the disease.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things discovery